News on Caduet from BioPortfolio.com http://www.BioPortfolio.com Consolidated Caduet news from BioPortfolio.com Wed, 10 Feb 2010 16:10:58 GMT en Mylan Confirms First-to-File Patent Challenge Relating to Caduethttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4037766&HITNO=0&MSIZE=34&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Caduet&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4037766&THISHREF=http://c.moreover.com/click/here.pl%3fz2537277134%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4037766&HITNO=0&MSIZE=34&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Caduet&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4037766&THISHREF=http://c.moreover.com/click/here.pl%3fz2537277134%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharma Live: Mylan Confirms First-to-File Patent Challenge Relating to Caduethttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4025337&HITNO=1&MSIZE=34&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Caduet&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4025337&THISHREF=http://c.moreover.com/click/here.pl%3fz2529671540%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4025337&HITNO=1&MSIZE=34&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Caduet&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4025337&THISHREF=http://c.moreover.com/click/here.pl%3fz2529671540%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharmaceuticalProcessing: Mylan first to file ANDA patent for Caduet Tabletshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4019355&HITNO=2&MSIZE=34&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Caduet&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4019355&THISHREF=http://c.moreover.com/click/here.pl%3fz2526241775%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4019355&HITNO=2&MSIZE=34&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Caduet&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4019355&THISHREF=http://c.moreover.com/click/here.pl%3fz2526241775%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comNews-Medical.Net: Mylan Confirms First-to-File Patent Challenge Relating to Caduet(R)http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4018046&HITNO=3&MSIZE=34&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Caduet&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4018046&THISHREF=http://c.moreover.com/click/here.pl%3fz2525447575%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4018046&HITNO=3&MSIZE=34&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Caduet&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4018046&THISHREF=http://c.moreover.com/click/here.pl%3fz2525447575%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharmacy Choice: Mylan Confirms First-to-File Patent Challenge Relating to Caduethttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4020741&HITNO=4&MSIZE=34&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Caduet&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4020741&THISHREF=http://c.moreover.com/click/here.pl%3fz2526986607%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4020741&HITNO=4&MSIZE=34&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Caduet&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4020741&THISHREF=http://c.moreover.com/click/here.pl%3fz2526986607%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comMDLinx: Pfizer files infringement suit against Mylan for Caduet generichttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4015972&HITNO=5&MSIZE=34&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Caduet&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4015972&THISHREF=http://c.moreover.com/click/here.pl%3fz2524593671%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4015972&HITNO=5&MSIZE=34&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Caduet&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4015972&THISHREF=http://c.moreover.com/click/here.pl%3fz2524593671%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comDrug Store News: Mylan Confirms First-to-File Patent Challenge Relating to Caduet(...http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4015126&HITNO=6&MSIZE=34&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Caduet&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4015126&THISHREF=http://c.moreover.com/click/here.pl%3fz2524287536%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4015126&HITNO=6&MSIZE=34&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Caduet&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4015126&THISHREF=http://c.moreover.com/click/here.pl%3fz2524287536%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comZibb: Mylan Confirms Pfizer Lawsuit Against Filing Of ANDA For Generic Caduet Tablets - Quick Factshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4015236&HITNO=7&MSIZE=34&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Caduet&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4015236&THISHREF=http://c.moreover.com/click/here.pl%3fz2524339006%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4015236&HITNO=7&MSIZE=34&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Caduet&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4015236&THISHREF=http://c.moreover.com/click/here.pl%3fz2524339006%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comRTTNews.com: Mylan Confirms First-to-File Patent Challenge Relating to Caduet(R)http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4016468&HITNO=8&MSIZE=34&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Caduet&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4016468&THISHREF=http://c.moreover.com/click/here.pl%3fz2524775501%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4016468&HITNO=8&MSIZE=34&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Caduet&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4016468&THISHREF=http://c.moreover.com/click/here.pl%3fz2524775501%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comSmartBrief: Mylan Confirms First-to-File Patent Challenge Relating to Caduet(R)http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4016455&HITNO=9&MSIZE=34&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Caduet&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4016455&THISHREF=http://c.moreover.com/click/here.pl%3fz2524770415%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4016455&HITNO=9&MSIZE=34&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Caduet&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4016455&THISHREF=http://c.moreover.com/click/here.pl%3fz2524770415%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comRed Orbit: Mylan Confirms First-to-File Patent Challenge Relating to Caduet(R)http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4016442&HITNO=10&MSIZE=34&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Caduet&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4016442&THISHREF=http://c.moreover.com/click/here.pl%3fz2524766610%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4016442&HITNO=10&MSIZE=34&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Caduet&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4016442&THISHREF=http://c.moreover.com/click/here.pl%3fz2524766610%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comRed Orbit: Mylan Confirms First-to-File Patent Challenge Relating to Caduet(R)http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4016439&HITNO=11&MSIZE=34&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Caduet&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4016439&THISHREF=http://c.moreover.com/click/here.pl%3fz2524765042%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4016439&HITNO=11&MSIZE=34&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Caduet&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4016439&THISHREF=http://c.moreover.com/click/here.pl%3fz2524765042%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comRed Orbit: Mylan Confirms First-to-File Patent Challenge Relating to Caduet(R)http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4016438&HITNO=12&MSIZE=34&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Caduet&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4016438&THISHREF=http://c.moreover.com/click/here.pl%3fz2524764969%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4016438&HITNO=12&MSIZE=34&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Caduet&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4016438&THISHREF=http://c.moreover.com/click/here.pl%3fz2524764969%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comRed Orbit: Mylan Confirms First-to-File Patent Challenge Relating to Caduet(R)http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4016346&HITNO=13&MSIZE=34&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Caduet&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4016346&THISHREF=http://c.moreover.com/click/here.pl%3fz2524727858%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4016346&HITNO=13&MSIZE=34&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Caduet&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4016346&THISHREF=http://c.moreover.com/click/here.pl%3fz2524727858%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPhiladelphia Business Journal: Mylan Confirms First-to-File Patent Challenge Relating to Caduet(R)http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4016237&HITNO=14&MSIZE=34&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Caduet&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4016237&THISHREF=http://c.moreover.com/click/here.pl%3fz2524687105%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4016237&HITNO=14&MSIZE=34&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Caduet&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4016237&THISHREF=http://c.moreover.com/click/here.pl%3fz2524687105%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comNewsBlaze: